SCHEMBL12426799

SCHEMBL12426799

C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCC(=O)O)cc23)c1

nearest known ligand 0.84

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 12/20 0.84
HDAC3 O15379 9/20 0.84
HDAC4 P56524 9/20 0.84
HDAC1 Q13547 9/20 0.84
HDAC7 Q8WUI4 9/20 0.84
HDAC2 Q92769 9/20 0.84
HDAC10 Q969S8 9/20 0.84
HDAC11 Q96DB2 9/20 0.84
HDAC8 Q9BY41 9/20 0.84
HDAC6 Q9UBN7 9/20 0.84
HDAC9 Q9UKV0 9/20 0.84
HDAC5 Q9UQL6 9/20 0.84
ERBB2 P04626 8/20 0.84
KDR P35968 4/20 0.83
GAK O14976 3/20 0.83
RIPK2 O43353 2/20 0.83
BUB1 O43683 2/20 0.83
STK10 O94804 2/20 0.83
ABL1 P00519 2/20 0.83
LCK P06239 2/20 0.83

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12426798 0.99 EGFR (0.84) EGFRHDAC3HDAC4HDAC1HDAC7
Erlotinib SCHEMBL27974794 0.93 EGFR (0.82) EGFRHDAC3HDAC4HDAC1HDAC7
SCHEMBL641765 0.93 EGFR (0.84) EGFRHDAC3HDAC4HDAC1HDAC7
SCHEMBL13882737 0.92 EGFR (0.84) EGFRHDAC3HDAC4HDAC1HDAC7
SCHEMBL8213005 0.91 HDAC3 (1.00) EGFRHDAC3HDAC4HDAC1HDAC7
SCHEMBL31424948 0.91 HDAC3 (1.00) EGFRHDAC3HDAC4HDAC1HDAC7
SCHEMBL643712 0.91 HDAC3 (1.00) EGFRHDAC3HDAC4HDAC1HDAC7
Cudc-101 SCHEMBL93769 0.91 HDAC3 (1.00) EGFRHDAC3HDAC4HDAC1HDAC7
SCHEMBL641667 0.91 HDAC3 (1.00) EGFRHDAC3HDAC4HDAC1HDAC7
Cudc-101 SCHEMBL29350202 0.91 HDAC3 (1.00) EGFRHDAC3HDAC4HDAC1HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9108929-B2 Quinazoline based EGFR inhibitors CURIS, INC. (US) 2015-08-18 US disclosed
US-9108929-B2 Quinazoline based EGFR inhibitors CURIS, INC. (US) 2015-08-18 US disclosed
US-8349856-B2 Quinazoline based EGFR inhibitors CURIS, INC. (US) 2013-01-08 US disclosed
US-8349856-B2 Quinazoline based EGFR inhibitors CURIS, INC. (US) 2013-01-08 US disclosed
US-7977347-B2 inhibitors of epidermal growth factor receptor tyrosine kinase; anticancer; 6-(4-(3-ethynylphenylamino)-7-methoxyquinazolin-6-yloxy)hexanoic acid CURIS, INC. (US) 2011-07-12 US disclosed
US-7977347-B2 inhibitors of epidermal growth factor receptor tyrosine kinase; anticancer; 6-(4-(3-ethynylphenylamino)-7-methoxyquinazolin-6-yloxy)hexanoic acid CURIS, INC. (US) 2011-07-12 US disclosed